Two new approaches prevent disease in a model of type 1 diabetes. One approach blocks an activation receptor on disease-conferring T cells. The second deploys suppressor T cells renowned for their ability to inhibit the local immune response.
This is a preview of subscription content, log in via an institution to check access.
Deborah Maizels
References
Ogasawara, K. et al. Immunity 20, 757–767 (2004).
Tang, Q. et al. J. Exp. Med. 199, 1455–1465 (2004).
Tarbell, K.V., Yamazaki, S., Olson, K., Toy, P. & Steinman, R.M. J. Exp. Med. 199, 1467–1477 (2004).
Khattri, R., Cox, T., Yasayko, S.A. & Ramsdell, F. Nat. Immunol. 4, 337–342 (2003).
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. J. Immunol. 155, 1151–1164 (1995).
Bruder, D. et al. Eur. J. Immunol. 34, 623–630 (2004).
Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Nat. Immunol. 4, 330–336 (2003).
Hori, S., Nomura, T. & Sakaguchi, S. Science 299, 1057–1061 (2003).
Jordan, M.S. et al. Nat Immunol. 2, 301–306 (2001).
Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Nat. Immunol. 3, 756–763 (2002).
Apostolou, I. & von Boehmer, H. J. Exp. Med. 199, 1401–1408 (2004).
von Boehmer, H. J. Exp. Med. 198, 845–849 (2003).
Shevach, E.M. Nat. Rev. Immunol. 2, 389–400 (2002).
Herman, A.E., Freeman, G.J., Mathis, D. & Benoist, C. J. Exp. Med. 199, 1479–1489 (2004).
Daniel, D. & Wegmann, D.R. Proc. Natl. Acad. Sci. USA 93, 956–960 (1996).
Diabetes Prevention Trial—Type 1 Diabetes Study Group. N. Engl. J. Med. 346, 1685–1691 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
von Boehmer, H. Type 1 diabetes: focus on prevention. Nat Med 10, 783–784 (2004). https://doi.org/10.1038/nm0804-783
Issue Date:
DOI: https://doi.org/10.1038/nm0804-783
- Springer Nature America, Inc.
This article is cited by
-
Mechanisms of suppression by suppressor T cells
Nature Immunology (2005)